We are live on ! Find out more
KALV

KalVista Pharmaceuticals

Delisted

KALV was delisted on the 10th of June, 2026.

Name Holding Trade Value Shares
Change
Change in
Stake
SHI
1
SV Health Investors
Massachusetts
$20.9M
RCM
2
RA Capital Management
Massachusetts
$11.7M
EAM
3
Eventide Asset Management
Massachusetts
$7.31M
IVM
4
InterWest Venture Management
California
$2.68M
IBT
5
International Biotechnology Trust
United Kingdom
$2.61M
VC
6
Vivo Capital
California
$2.44M
Vanguard Group
7
Vanguard Group
Pennsylvania
$954K +$3.48K +394 +0.3%
SLG
8
Stanley-Laman Group
Pennsylvania
$545K +$193K +21,861 +48%
TI
9
Telemetry Investments
New York
$447K +$486K +55,104 New
BCM
10
Bridgeway Capital Management
Texas
$333K
Renaissance Technologies
11
Renaissance Technologies
New York
$290K -$68K -7,700 -18%
Deutsche Bank
12
Deutsche Bank
Germany
$205K -$159K -18,017 -42%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$168K
DS
14
DRW Securities
Illinois
$167K +$49.4K +5,600 +37%
BlackRock
15
BlackRock
New York
$132K +$96K +10,871 +204%
SIM
16
Spark Investment Management
New York
$108K +$118K +13,400 New
Millennium Management
17
Millennium Management
New York
$107K -$1.91M -216,131 -94%
JP Morgan Chase
18
JP Morgan Chase
New York
$59K -$121K -13,678 -65%
FQ
19
First Quadrant
California
$37K
UBS Group
20
UBS Group
Switzerland
$25K +$26.2K +2,969 +2,048%
PCM
21
Prelude Capital Management
New York
$8K +$6.48K +734 +245%
Morgan Stanley
22
Morgan Stanley
New York
$6K +$6.38K +723 +1,763%
TRCT
23
Tower Research Capital (TRC)
New York
$3K -$8.41K -953 -74%
Manulife (Manufacturers Life Insurance)
24
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2K
VFA
25
Valeo Financial Advisors
Indiana
$2K